DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 8Dr. Reddy's Laboratories
02 2Olpha
03 6Granules India Limited
04 42care4
05 1Accord healthcare
06 2Adamed Pharma
07 1Alhavi Pharma
08 2Alkem Laboratories
09 2Alter Laboratories Sa
10 2Annora Pharma
11 1Aurobindo Pharma Limited
12 1Aurovitas Spain, Sau
13 1Bausch Health
14 74Boehringer Ingelheim GmbH
15 3CLONMEL HLTHCARE
16 2Cinfa Laboratories Sa
17 1Combix Laboratories Slu
18 1Demo S.A.
19 3Grindeks AS
20 3Grupo Azevedos
21 3Innovis Pharma Sa
22 4Intas Pharmaceuticals
23 1Intas Third Party Sales 2005 Sl
24 1InvaGen Pharmaceuticals Inc
25 1Kern Pharma S.L.
26 2Kinapse
27 3Krka
28 3Laboratorios Lafage
29 3MEDOCHEMIE LTD
30 6MSN Laboratories
31 1Mahban Group
32 2Novalie Pharma Bv
33 4PharOS Ltd
34 5PharmaPath S.A.
35 4Pharmaline
36 8Pharmapath Sa
37 2Pharos Pharmaceutical Oriented Services Ltd.
38 3Pluviaendo
39 3Prinston
40 9STADA Arzneimittel
41 12Sandoz B2B
42 3Sun Pharmaceutical Industries Limited
43 4Sunshine Lake Pharma
44 2Tarbis Farma Sl
45 2Tecnimede
46 3Varian Pharmed
47 9Viatris
48 6Zentiva
49 4Zydus Pharmaceuticals
01 3Each Coated Tablet
02 116Film Coated Tablet
03 4Film Coated Tablet
04 14Film-Coated Tablet
05 6Immediate Release Tablet
06 1Linagliptin 5Mg 28 Combined Oral Use
07 1Metformin+Linagliptin+2,51,000 Mg 56 Combined Oral Use
08 1Metformin+Linagliptin+2,5850 Mg 56 Combined Oral Use
09 4Oral
10 4TABLET
11 6TABLET, EXTENDED RELEASE;ORAL
12 4TABLET; ORAL
13 38TABLET;ORAL
14 19Tablet
15 2Tablets
16 1Tablets
17 2tablet
18 7Blank
01 5Allowed
02 10Approved
03 18Authorised
04 39Authorized
05 1Dossier Readiness: Q1 2025
06 2Generic
07 6Marketed
08 8Not Marketed
09 39Prescription
10 31RX
11 1Withdrawn
12 73Blank
01 1Abbreviation "Sandoz"
02 2Autnami
03 1Diagliptin Deo
04 1Donumid
05 1Drojarto
06 3EMPAGLIFLOZIN AND LINAGLIPTIN
07 6EMPAGLIFLOZIN; LINAGLIPTIN
08 2Empagliflozin ; Linagliptin
09 1Empiria Complex
10 1Empiria Complex
11 2GLYXAMBI
12 2Gentadueto
13 2Girl Duet
14 4Glymetia
15 12Glyxambi
16 1Glyxambi
17 2Ilinpru
18 6JENTADUETO
19 2JENTADUETO XR
20 26Jentadueto
21 3Jentadueto mg
22 7LINAGLIPTIN
23 1LINAGLIPTIN 5
24 17LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
25 3LINAGLIPTIN; METFORMIN HYDROCHLORIDE
26 2Liglifev
27 1Liglinra
28 2Linagliptin
29 3Linagliptin ; Metformin
30 3Linagliptin ; Metformin Hydrochloride
31 1Linagliptin Accord
32 1Linagliptin Aurovitas
33 1Linagliptin Combix
34 1Linagliptin Intas
35 1Linagliptin Kern Pharma
36 1Linagliptin Krka
37 1Linagliptin Medochemie5
38 1Linagliptin Medochemistry
39 1Linagliptin Olpha
40 1Linagliptin Pharos
41 3Linagliptin Sandoz
42 1Linagliptin Stada
43 2Linagliptin Viatris
44 1Linagliptin Zentiva
45 1Linagliptin "Krka"
46 1Linagliptin "Stada"
47 1Linagliptin "Viatris"
48 1Linagliptin “Pharmapathâ€
49 2Linagliptin/Metformin Cinfa
50 3Linagliptin/Metformin Clonmel
51 3Linagliptin/Metformin Hcl Pharos
52 2Linagliptin/Metformin Pharos
53 3Linagliptin/Metformin Sandoz
54 3Linagliptin/Metformin Stada
55 2Linagliptin/Metformin Tarbis
56 1Linagliptina Alter
57 1Linagliptina Medochemie
58 1Linagliptina Pharmapath
59 1Linagliptina Stada
60 2Linagliptina/Metformina Sandoz
61 2Linagliptine/Metformin Stada
62 2Linathan
63 1Lynxaram
64 4Meglithan
65 1Melijent
66 2Nagilma
67 1Neloviren
68 1Nezodia
69 1Sansik
70 1TRADJENTA
71 1TRAJENTA
72 4TRIJARDY XR
73 1Tingapla
74 10Trajenta
75 6Trajentamet
76 1Zyfoqam
77 29Blank
01 12Australia
02 4Canada
03 4Czech Republic
04 21Denmark
05 14Estonia
06 3Guatemala
07 14India
08 5Iran
09 3Italy
10 4Latvia
11 4Lebanon
12 19Malta
13 14Norway
14 2Poland
15 5Portugal
16 39Spain
17 10Sweden
18 5Switzerland
19 3Turkey
20 48USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q1 2025
Registration Country : Latvia
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 10MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : LINAGLIPTIN AND METFORMIN HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2025-11-03
Application Number : 208427
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : LINAGLIPTIN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2025-11-03
Application Number : 208428
Regulatory Info : RX
Registration Country : USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Oral
Dosage Strength : 5 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin
Dosage Form : Oral
Dosage Strength : 2.5 mg / 500 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin
Dosage Form : Oral
Dosage Strength : 2.5 mg / 850 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin
Dosage Form : Oral
Dosage Strength : 2.5 mg / 1 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Linagliptin Olpha
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date : 24-11-2025
Application Number : 90773
Regulatory Info : Authorized
Registration Country : Spain
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Empagliflozin ; Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 25MG; 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin
Dosage Form : Immediate Release Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 850MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Regulatory Info :
Registration Country : India
Brand Name : Linagliptin ; Metformin Hydrochloride
Dosage Form : Immediate Release Tablet
Dosage Strength : 2.5MG; 1000MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : RX
Registration Country : USA
Brand Name : TRADJENTA
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2011-05-02
Application Number : 201280
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;500MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;850MG
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LINAGLIPTIN; METFORMIN HYDROCHLORIDE
Brand Name : JENTADUETO
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;1GM
Packaging :
Approval Date : 2012-01-30
Application Number : 201281
Regulatory Info : RX
Registration Country : USA
